| CAS No. | 185913-78-4 |
|---|---|
| MDL No. | N/A |
| MF | C33H45N3O8S |
| MW | 643.80 |
| InChI Key | QKXJWFOKVQWEDZ-UHFFFAOYSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Satavaptan is a vasopressin V2 receptor antagonist used to improve hyponatremia in patients with cirrhosis, congestive heart failure, and syndrome of inappropriate antidiuresis. It functions as a vasopressin receptor antagonist and aquaretic. Chemically, it is a morpholine, aromatic ether, benzamide, secondary carboxamide, monomethoxybenzene, sulfonamide, and oxaspiro compound.
| CAS No. | 185913-78-4 |
|---|---|
| Product Name | Satavaptan |
| Heavy Atom Count | 45 | Rotatable Bond Count | 10 |
| Atom Stereo Count | 0 | Bond Stereo Count | 0 |
| HBA | 9 | HBD | 1 |
| TPSA | 123.710 Ų | Charge | 0 |
| Exact Mass | 643.29274 | Complexity | 1506.28 |
| pKa | 5.875 | XLogP | 3.887 |
